These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 94683)

  • 1. [Ribosomal vaccines].
    Timoşca S; Petreanu V; Lişca M
    Rev Med Chir Soc Med Nat Iasi; 1979; 83(1):21-5. PubMed ID: 94683
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection of chickens by ribosomal vaccines from Pasteurella multocida: dependence on homologous lipopolysaccharide.
    Phillips M; Rimler RB
    Am J Vet Res; 1984 Sep; 45(9):1785-9. PubMed ID: 6208828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biological aerosols and microaerosols (survival, decay, immunizations). II].
    Mammarella L
    Nuovi Ann Ig Microbiol; 1972; 23(1):35-51. PubMed ID: 4660367
    [No Abstract]   [Full Text] [Related]  

  • 4. [Endotoxic contamination of biological products (ribosomal vaccines, viral vaccines and interferon)].
    Fumarola D; Panaro A; Palma R; Mazzone A
    G Batteriol Virol Immunol; 1979; 72(1-6):72-7. PubMed ID: 95449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribosomal vaccines: introduction to the study of ribosomal vaccines.
    Dussourd d'Hinterland L
    Arzneimittelforschung; 1980; 30(1a):122-5. PubMed ID: 6154466
    [No Abstract]   [Full Text] [Related]  

  • 6. Invasive diseases: new vaccines and vaccination strategies.
    Crovari P
    J Prev Med Hyg; 2012 Jun; 53(2):49. PubMed ID: 23240159
    [No Abstract]   [Full Text] [Related]  

  • 7. DNA vaccines for biodefence.
    Garmory HS; Perkins SD; Phillpotts RJ; Titball RW
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1343-61. PubMed ID: 15935877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Travel vaccination.
    Lau S; Gherardin T
    Aust Fam Physician; 2007 May; 36(5):304-11. PubMed ID: 17492062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summaries, recommendations, conclusions of the Proceedings of the 12th International Congress for Microbiological Standardization, Annecy 1971.
    Prog Immunobiol Stand; 1971; 5():542-51. PubMed ID: 4676691
    [No Abstract]   [Full Text] [Related]  

  • 10. In ovo vaccination technology.
    Ricks CA; Avakian A; Bryan T; Gildersleeve R; Haddad E; Ilich R; King S; Murray L; Phelps P; Poston R; Whitfill C; Williams C
    Adv Vet Med; 1999; 41():495-515. PubMed ID: 9890038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Should we vaccinate patients with systemic lupus].
    Wiesik-Szewczyk E; Lacki JK; Chwalińiska-Sadowska H
    Pol Merkur Lekarski; 2007 Nov; 23(137):395-8. PubMed ID: 18361328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Exciting progress in the field of infection medicine. Several breakthroughs are to be expected during the next decade].
    Andersson J; Iwarson S
    Lakartidningen; 1999 Dec; 96(48):5371-3. PubMed ID: 10612988
    [No Abstract]   [Full Text] [Related]  

  • 13. Enteric vaccines.
    Edelman R; Levine MM
    Md Med J; 1991 Mar; 40(3):199-203. PubMed ID: 2008164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of Moraxella bovis ribosomes and their subsequent use in a vaccine against infectious bovine keratoconjunctivitis.
    Pugh GW; Phillips M; McDonald TJ; Kopecky KE
    Am J Vet Res; 1981 Mar; 42(3):516-20. PubMed ID: 7271018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspects of vaccine development. Introduction.
    Girard MP
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):73-5. PubMed ID: 17707507
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of antituberculous immunity by polysaccharidic contaminants of crude ribosomal vaccines isolated from Mycobacterium bovis, strain BCG.
    Portelance V; Boulanger RP; Brasseur R
    Rev Can Biol; 1977 Sep; 36(3):265-75. PubMed ID: 928854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of hepatitis B vaccine with other vaccines--laboratory animals study.
    Mazert MC; Chabanier G; Adamowicz P; Gerfaux G
    Dev Biol Stand; 1983; 54():53-62. PubMed ID: 6228476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral vectors for use in the development of biodefense vaccines.
    Lee JS; Hadjipanayis AG; Parker MD
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1293-314. PubMed ID: 15935875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically engineered vaccines: problems and promises.
    Brown F; Dougan G; Snary D
    Microbiol Sci; 1984 Aug; 1(5):123-7. PubMed ID: 6444113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular-biological and immunological properties of ribosomal vaccines.
    Nikolaeva LV; Savel'ev EP
    Biomed Sci; 1991; 2(1):1-10. PubMed ID: 1912243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.